Classification
- Anatomical main groupJAnti-infectives for systemic use
- Therapeutic subgroupJ01
- Pharmacological subgroupJ01C
- Chemical subgroupJ01CA
- Chemical substanceJ01CA12Piperacillin
Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 66 registrations
- Piperacillin and Tazobactam for Injection3.000 G / VIAL + 0.375 G / VIAL · Powder For Solution · Sterimax INC
- Piperacillin and Tazobactam for Injection12 G / VIAL + 1.5 G / VIAL · Powder For Solution · Sandoz Canada Incorporated
- Piperacillin and Tazobactam for Injection2 G / VIAL + 0.25 G / VIAL · Powder For Solution · Auro Pharma INC
- Piperacillin and Tazobactam for Injection3 G / VIAL + 0.375 G / VIAL · Powder For Solution · Sandoz Canada Incorporated
Brazil
Anvisa · 26 registrations
At a glance
- ATC code
- J01CA12
- ATC group
- Anti-infectives for systemic use
- Registers
- 9
- Historical lists
- 2
- Registrations
- 174
- With their own page
- 96
- Companies
- 83
All medicines with Piperacillin
Human medicines from every register that match Piperacillin by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
175 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Piperacillin | United States | 2GM BASE/VIAL, 3GM BASE/VIAL, 40GM BASE/VIAL … | injectable | Marketed | Istituto Bio Ita SPA |
| Piperacillin and TazobactamCombination | United States | 12GM BASE/VIAL; 1.5GM BASE/VIAL, 2GM BASE/VIAL; 250MG BASE/VIAL, 36GM BASE/VIAL; 4.5GM BASE/VIAL … | injectable | Marketed | Apotex |
| Piperacillin and TazobactamCombination | United States | 0.375G, 0.5G/1VIAL, 12GM BASE/VIAL … | injection | Marketed | Eugia Pharma |
| Piperacillin/Tazobactam KabiCombination | Serbia | 4g+0.5g | prašak za rastvor za infuziju | Authorised | Fresenius Kabi D.O.O. Beograd |
| Piperacillin/Tazobactam KabiCombination | Serbia | 4g+0.5g | prašak za rastvor za infuziju | Authorised | Fresenius Kabi D.O.O. Beograd |
| Piperacillin and Tazobactam and Sodium Chloride in Duplex ContainerCombination | United States | 2GM BASE/VIAL; 250MG BASE/VIAL, 3GM BASE/VIAL; 375MG BASE/VIAL, 4GM BASE/VIAL; 500MG BASE/VIAL | powder | Marketed | B Braun Medical |
| Piperacillin and Tazobactam for InjectionCombination | Canada | 3 G / VIAL + 0.375 G / VIAL | Powder For Solution | Marketed | Eugia Pharma INC. |
| Piperacillin and Tazobactam for InjectionCombination | Canada | 2 G / VIAL + 0.25 G / VIAL | Powder For Solution | Marketed | Auro Pharma INC |
| Piperacillin and Tazobactam for InjectionCombination | Canada | 4.0 G / VIAL + 0.5 G / VIAL | Powder For Solution | Marketed | Sterimax INC |
| Piperacillin and Tazobactam for InjectionCombination | Canada | 4 G / VIAL + 0.5 G / VIAL | Powder For Solution | Marketed | Auro Pharma INC |
| Piperacillin and Tazobactam for InjectionCombination | Canada | 3.000 G / VIAL + 0.375 G / VIAL | Powder For Solution | Marketed | Sterimax INC |
| Piperacillin and Tazobactam for InjectionCombination | Canada | 2 G / VIAL + 0.25 G / VIAL | Powder For Solution | Marketed | Eugia Pharma INC. |
| Piperacillin and Tazobactam for InjectionCombination | Canada | 12 G / VIAL + 1.5 G / VIAL | Powder For Solution | Marketed | Sandoz Canada Incorporated |
| Piperacillin and Tazobactam for InjectionCombination | Canada | 4 G / VIAL + 0.5 G / VIAL | Powder For Solution | Marketed | Sandoz Canada Incorporated |
| Piperacillin and Tazobactam for InjectionCombination | Canada | 3 G / VIAL + 0.375 G / VIAL | Powder For Solution | Marketed | Sandoz Canada Incorporated |
| Piperacillin and Tazobactam for InjectionCombination | Canada | 4 G / VIAL + 0.5 G / VIAL | Powder For Solution | Marketed | Eugia Pharma INC. |
| Piperacillin and Tazobactam for InjectionCombination | Canada | 2.00 G / VIAL + 0.25 G / VIAL | Powder For Solution | Marketed | Sterimax INC |
| Piperacillin and Tazobactam for InjectionCombination | Canada | 36 G / VIAL + 4.5 G / VIAL | Powder For Solution | Marketed | Sandoz Canada Incorporated |
| Piperacillin and Tazobactam for InjectionCombination | Canada | 12 G / VIAL + 1.5 G / VIAL | Powder For Solution | Marketed | Sterimax INC |
| Piperacillin and Tazobactam for InjectionCombination | Canada | 2 G / VIAL + 0.25 G / VIAL | Powder For Solution | Marketed | Sandoz Canada Incorporated |
| Piperacillin and Tazobactam for InjectionCombination | Canada | 36 G / VIAL + 4.5 G / VIAL | Powder For Solution | Marketed | Sterimax INC |
| Piperacillin and Tazobactam for InjectionCombination | Canada | 3 G / VIAL + 0.375 G / VIAL | Powder For Solution | Marketed | Auro Pharma INC |
| Piperacillin and Tazobactam for InjectionCombination | Canada | 36 G / VIAL + 4.5 G / VIAL | Powder For Solution | Authorised | Eugia Pharma INC. |
| Piperacillin and Tazobactam for InjectionCombination | Canada | 3 G / VIAL + 0.375 G / VIAL | Powder For Solution | Authorised | Marcan Pharmaceuticals INC |
| Piperacillin and Tazobactam for InjectionCombination | Canada | 2 G / VIAL + 0.25 G / VIAL | Powder For Solution | Authorised | Marcan Pharmaceuticals INC |